de Souza Paloma Silva, Cruz André L S, Viola João P B, Maia Raquel C
Program of Hemato-Oncology Molecular, Brazilian National Cancer Institute, Rio de Janeiro, Brazil.
Cancer Sci. 2015 Jan;106(1):60-8. doi: 10.1111/cas.12566. Epub 2014 Dec 15.
Multidrug resistance (MDR) is considered a multifactorial event that favors cancer cells becoming resistant to several chemotherapeutic agents. Numerous mechanisms contribute to MDR, such as P-glycoprotein (Pgp/ABCB1) activity that promotes drug efflux, overexpression of inhibitors of apoptosis proteins (IAP) that contribute to evasion of apoptosis, and oncogenic pathway activation that favors cancer cell survival. MDR molecules have been identified in membrane microparticles (MP) and can be transferred to sensitive cancer cells. By co-culturing MP derived from MDR-positive cells with recipient cells, we showed that sensitive cells accumulated Pgp, IAP proteins and mRNA. In addition, MP promoted microRNA transfer and NFκB and Yb-1 activation. Therefore, our results indicate that MP can induce a multifactorial phenotype in sensitive cancer cells.
多药耐药性(MDR)被认为是一个多因素事件,它促使癌细胞对多种化疗药物产生耐药性。多种机制导致了MDR,例如促进药物外排的P-糖蛋白(Pgp/ABCB1)活性、有助于逃避凋亡的凋亡抑制蛋白(IAP)过表达以及有利于癌细胞存活的致癌途径激活。已在膜微粒(MP)中鉴定出MDR分子,并且这些分子可以转移至敏感癌细胞。通过将源自MDR阳性细胞的MP与受体细胞共培养,我们发现敏感细胞积累了Pgp、IAP蛋白和mRNA。此外,MP促进了微小RNA转移以及NFκB和Yb-1激活。因此,我们的结果表明MP可在敏感癌细胞中诱导多因素表型。